Patents by Inventor Ewa Anna Bienkiewicz

Ewa Anna Bienkiewicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000571
    Abstract: An example of the composition incudes at least one amino acid sequence from the octarepeat region of hemin that is modified by substituting at least one proline (P) residue in the amino acid sequence. The composition is effective to bind with hemin and for treating hemorrhagic injury.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: May 11, 2021
    Assignee: Florida State University Research Foundation, Inc.
    Inventor: Ewa Anna Bienkiewicz
  • Patent number: 10449213
    Abstract: A therapeutically effective composition for treating Alzheimer's disease includes a pharmaceutically acceptable dosage form comprising melatonin, resveratrol, EGCG, and vitamin B12 combined in a therapeutically effective amount. A combinatorial treatment method for Alzheimer's disease includes administering to a human having Alzheimer's disease a therapeutically effective combination of melatonin, resveratrol, EGCG, and vitamin B12. A method of treating Alzheimer's disease includes administering to a human having Alzheimer's disease a therapeutically effective amount of a pharmaceutically acceptable dosage form comprising melatonin, resveratrol, EGCG, and vitamin B12.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: October 22, 2019
    Assignee: The Florida State University Research Foundation, Inc.
    Inventor: Ewa Anna Bienkiewicz
  • Publication number: 20170368137
    Abstract: An example of the composition incudes at least one amino acid sequence from the octarepeat region of hemin that is modified by substituting at least one proline (P) residue in the amino acid sequence. The composition is effective to bind with hemin and for treating hemorrhagic injury.
    Type: Application
    Filed: June 26, 2017
    Publication date: December 28, 2017
    Inventor: Ewa Anna Bienkiewicz
  • Publication number: 20160303160
    Abstract: A therapeutically effective composition for treating Alzheimer's disease includes a pharmaceutically acceptable dosage form comprising melatonin, resveratrol, EGCG, and vitamin B12 combined in a therapeutically effective amount. A combinatorial treatment method for Alzheimer's disease includes administering to a human having Alzheimer's disease a therapeutically effective combination of melatonin, resveratrol, EGCG, and vitamin B12. A method of treating Alzheimer's disease includes administering to a human having Alzheimer's disease a therapeutically effective amount of a pharmaceutically acceptable dosage form comprising melatonin, resveratrol, EGCG, and vitamin B12.
    Type: Application
    Filed: June 28, 2016
    Publication date: October 20, 2016
    Inventor: Ewa Anna Bienkiewicz
  • Publication number: 20150065449
    Abstract: A method of treating amyloid-beta peptide aggregation in a subject includes contacting at least one amyloid-beta peptide oligomer formed from a plurality of amyloid-beta peptide monomers with a composition containing melatonin, resveratrol, EGCG, and an effective amount of vitamin B12. The effective amount of vitamin B12 being sufficient to stimulate dissociation of the amyloid-beta peptide monomers from the at least one amyloid-beta peptide oligomer. The composition may be used to treat amyloidosis, including Alzheimer's disease.
    Type: Application
    Filed: November 12, 2014
    Publication date: March 5, 2015
    Inventor: Ewa Anna Bienkiewicz